February 2024 - Page 3 of 5 - CannabisNewsWire

ThursdayFeb 15, 2024 9:45 am

New England Cannabis Convention To Be Held In Boston, MA

Businesses, leaders, enthusiasts, and service providers of the cannabis spectrum are all invited to the NECANN Boston Convention, the 2nd largest B2B cannabis industry event across the globe. Since its 70th booth convention back in 2015, NECANN has come a long way. This year’s convention will feature over 350 exhibitors, several workshops, five full programming tracks, and a day-long financial/investor summit. The age limit to attend the conference is 18+ unless accompanied by a guardian. The NECANN event is a phenomenal business platform attracting the New England cannabis trading community and other visitors. Influential cannabis industry leaders will be at…

WednesdayFeb 14, 2024 4:20 pm

420 with CNW — Teenage Brains More Susceptible to Cannabis Harm

Only 35% of 12- to-17-year-olds believe that smoking cannabis at least twice a week carries a major risk, according to the 2021 National Survey on Drug Use and Health (NSDUH). This low perception of risk among teenagers is concerning and is partly fueled by the widespread availability of marijuana, leading to the mistaken belief that it is entirely safe, states Beth Ebel, a pediatrician affiliated with Seattle Children’s Hospital and the University of Washington School of Medicine. The main psychoactive ingredient in cannabis, THC, alters brain chemistry to produce a “high.” The THC may have unexpected consequences on the brain,…

WednesdayFeb 14, 2024 9:45 am

Study Says Cannabis Doesn’t Up Vehicle Accident Risk But Alcohol Intake Does

A recent study has revealed that cannabis use alone is not associated with an increased risk of traffic accidents. Researchers looked at data collected from emergency departments in Portland, Oregon; Sacramento, California; and Denver, Colorado; they found that self-reported rates of acute marijuana use were linked with lower car-accident odds. Furthermore, the researchers found that alcohol has a clear connection with an increased risk of car accidents when taken by itself or alongside cannabis. The team behind the study comprised researchers from the University of California Davis, the Oregon Health and Science University, the Insurance Institute for Highway Safety, Portland…

WednesdayFeb 14, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks off 2024 with FDA IND Submission for its HYPER-H23-1 Phase 1b Human Clinical Trial

Lexaria, a global innovator in drug delivery platforms, just announced the submission of its IND application with the FDA for its HYPER-H23-1 phase 1b hypertension clinical trial This study will seek to evaluate the safety and tolerability of Lexaria’s patented DehydraTECH(TM) technology, specifically DehydraTECH-CBD, in hypertensive patients Lexaria expects to build on success of its previous studies, which showed positive results and DehydraTECH-CBD’s potential to have broad therapeutic utility Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the submission of its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”)…

TuesdayFeb 13, 2024 4:20 pm

420 with CNW — Judge Rejects Challenge by Out-of-State Residents Against New York’s Cannabis Program

A recent ruling by a federal judge Anne M. Nardacci has dismissed a lawsuit challenging New York’s cannabis licensing program. The lawsuit, filed by two applicants from California, argued that the program unfairly discriminates against non-New York state residents. The ruling would allow the state to grant more licenses, which would have a big effect on a market that is primarily controlled by illegal businesses. According to Nardacci, the public’s interest in allowing legitimately licensed entities to dominate the market outweighs the issues brought up by the plaintiffs. She noted that the plaintiffs-cited dormant Commerce Provision does not apply to…

MondayFeb 12, 2024 4:20 pm

420 with CNW — Virginia Assembly Committee Approves Cannabis Bill Permitting Sales

A recently amended measure, HB 698, advanced by a Virginia Assembly subcommittee, seeks to permit existing medical cannabis dispensaries and certain small businesses to commence recreational marijuana sales in January next year, with more retailers expected to be licensed by year-end. A medical marijuana operator has to quickly establish six microbusinesses to capitalize on an early launch date. The present form of the law would provide $400,000 in funding to each of these microbusinesses. In turn, microbusiness licenses would require that at least two-thirds of the individuals directly controlling the enterprise meet certain social-equity requirements, with preference going to those…

MondayFeb 12, 2024 10:15 am

Experts Say New Rules by Israeli Authorities Could Trigger Growth for Marijuana Industry

Last month, Israel’s Ministry of Health implemented rules that would make it easier for physicians to administer medical marijuana to their patients. In a statement, the ministry explained that these changes would improve availability of marijuana, decrease bureaucracy for patients who needed the drug and increase medical autonomy of the physicians. The ministry also noted that emphasis was being placed on affording physicians more discretion to administer medical marijuana in their areas of expertise for a range of indications. Bazelet Group’s Head of business development, Itai Rogel, stated in an email that prior to this change in policy, marijuana was…

MondayFeb 12, 2024 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) CEO, Chris Bunka, Shares 2023 Company Update and 2024 Roadmap in Annual Letter

Lexaria, a global innovator in drug delivery platforms, just announced ambitious plans for the 2024 calendar year The letter confirms that the 2024 plans have been made possible by significant strides that were made by the company in 2023 Lexaria looks to build on the momentum gained from the previous year, ultimately asserting market dominance and making 2024 its best year yet Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its ambitious plans for the 2024 calendar year. In his annual letter, Chris Bunka, Lexaria’s CEO, noted that this would mark the year that will…

FridayFeb 09, 2024 4:20 pm

420 with CNW — Texas AG Wants Court to Reverse Cannabis Decriminalization in Five Cities

Texas attorney general Ken Paxton is asking the court to overturn cannabis decriminalization policies passed and implemented in five cities and has vowed to overrule the “pro-crime extremists” who championed cannabis reform in the Texas cities. The Republican filed suits against the cities of San Marcos, Austin, Denton, Killeen and Elgin earlier this week to overturn their voter-passed cannabis decriminalization measures. In the filings, Paxton cited relevant state constitutional and statute provisions and argued that these provisions prevented local governments from approving policies that were in conflict with state law. The AG also issued a press release stating that he…

FridayFeb 09, 2024 9:30 am

Marijuana Officials Want Minnesota Lawmakers to Authorize Temporary Industry Licenses

Marijuana officials in the state of Minnesota are urging lawmakers to consider amendments to licensing processes to help meet its retail cannabis sales goals. Charlene Briner, the interim director of the Office of Cannabis Management, stated in a recent webinar that the agency was focused on hiring staff and building infrastructure needed to oversee the legal marijuana marketplace. Regulators plan to test how efficient an online license application system designed for businesses works in the spring. Briner also revealed that she was hopeful that when legislators resumed their legislative session, they would amend the law to allow for a successful…